Evolution of Antibiotic Resistance in Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Multi-Profile Hospital over 5 Years (2017-2021)

• Published in: Journal of clinical medicine 2023-03, Vol.12 (6), p.2414
• Main Authors: Mączyńska, Beata, Frej-Mądrzak, Magdalena, Sarowska, Jolanta, Woronowicz, Krystyna, Choroszy-Król, Irena, Jama-Kmiecik, Agnieszka
• Format: Article
• Language: English
• Subjects: Antibiotics; Antimicrobial agents; Bacteria; Clinical medicine; Drug resistance; E coli; Enzymes; Evolution; Identification; Infections; Microorganisms; Pathogens; Plasmids; Proteins
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12062414

In recent years, we have witnessed a growing drug resistance among bacteria, which is associated with the use and availability of an increasing number of broad-spectrum antimicrobial agents, as well as with their irrational and excessive use. The present study aims to analyze changes in the drug resistance of Gram-negative : and , isolated from infections in a multi-profile hospital over five years (from 2017 to 2021). Among the practical outcomes of the evaluation of these data will be the possibility of determining changes in susceptibility to the antibiotics used in the hospital. In turn, this will help propose new therapeutic options, especially for empirical therapy that is necessary in severe infections. The analysis of the use of individual groups of antibiotics allowed for identification of the causes of the increasing resistance of Gram-negative bacilli. The highest number of infections whose etiological agent was ESBL(+) and ESBL(+) was observed in 2018. In the analyzed five-year period, the number of multi-resistant (MDR) strains increased successively, which seems to be related to the growing use, especially in the pandemic period, of broad-spectrum antibiotics, mainly penicillins with inhibitors, third-generation cephalosporins, and carbapenems.